Sign up to save your podcasts
Or
Share 30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 7 Design of Experiments (D.O.E.) in Process Optimization
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 7 Design of Experiments (D.O.E.) in Process Optimization
This podcast episode explores Design of Experiments (DOE) in pharmaceutical development, particularly focusing on optimizing processes for compounds like dronabinol and psilocybin. The discussion covers three main types of DOE - factorial designs, fractional factorial designs, and response surface methodology (RSM). The episode explains how these methodologies help scientists systematically optimize manufacturing processes while ensuring product quality and safety through Quality by Design (QbD) principles. The experts discuss practical applications, including how DOE helps identify critical process parameters, manage risks, and ensure consistent product quality in pharmaceutical manufacturing.
View all episodes
By Jim Mitchell and Google NotebookLMThis podcast episode explores Design of Experiments (DOE) in pharmaceutical development, particularly focusing on optimizing processes for compounds like dronabinol and psilocybin. The discussion covers three main types of DOE - factorial designs, fractional factorial designs, and response surface methodology (RSM). The episode explains how these methodologies help scientists systematically optimize manufacturing processes while ensuring product quality and safety through Quality by Design (QbD) principles. The experts discuss practical applications, including how DOE helps identify critical process parameters, manage risks, and ensure consistent product quality in pharmaceutical manufacturing.